Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study

• Main Authors: Kandace L. Amend (Author), Bruce Turnbull (Author), Li Zhou (Author), Morgan A. Marks (Author), Christine Velicer (Author), Patricia Saddier (Author), John D. Seeger (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The 4-valent human papillomavirus (HPV) vaccine (4vHPV vaccine), Gardasil®, is indicated for the prevention of several HPV-related diseases. The objective was to assess the safety of 4vHPV vaccine administered to males as part of routine care. The study used a US health insurance claims database, an...